{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:51:59Z","timestamp":1788000719355,"version":"build-2784847793"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T00:00:00Z","timestamp":1771113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R41EY034396"],"award-info":[{"award-number":["R41EY034396"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-40211-4","type":"journal-article","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T08:54:12Z","timestamp":1771145652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clusterin reverses epitheliopathy, reduces inflammation, and restores goblet cells and corneal nerves in a mouse model of autoimmune dry eye"],"prefix":"10.1038","volume":"16","author":[{"given":"Jonas","family":"Franz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tat Fong","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivali","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Elizabeth","family":"Fini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmila","family":"Masli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,15]]},"reference":[{"key":"40211_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cger.2016.08.007","volume":"33","author":"AN Baer","year":"2017","unstructured":"Baer, A. N. & Walitt, B. Sj\u00f6gren syndrome and other causes of Sicca in older adults. Clin. Geriatr. Med. 33, 87\u2013103. https:\/\/doi.org\/10.1016\/j.cger.2016.08.007 (2017).","journal-title":"Clin. Geriatr. Med."},{"key":"40211_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40674-018-0084-4","volume":"4","author":"JA Gonzales","year":"2018","unstructured":"Gonzales, J. A. & Lietman, T. M. Ocular involvement in Sj\u00f6gren\u2019s syndrome: advances in therapy. Curr. Treat. Options Rheumatol. 4, 99\u2013109. https:\/\/doi.org\/10.1007\/s40674-018-0084-4 (2018).","journal-title":"Curr. Treat. Options Rheumatol."},{"key":"40211_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.clim.2019.04.009","volume":"203","author":"FB Vivino","year":"2019","unstructured":"Vivino, F. B. et al. Sjogren\u2019s syndrome: an update on disease pathogenesis, clinical manifestations and treatment. Clin. Immunol. 203, 81\u2013121. https:\/\/doi.org\/10.1016\/j.clim.2019.04.009 (2019).","journal-title":"Clin. Immunol."},{"key":"40211_CR4","doi-asserted-by":"publisher","first-page":"108295","DOI":"10.1016\/j.exer.2020.108295","volume":"201","author":"SC Pflugfelder","year":"2020","unstructured":"Pflugfelder, S. C. & Stern, M. E. The cornea in keratoconjunctivitis Sicca. Exp. Eye Res. 201, 108295. https:\/\/doi.org\/10.1016\/j.exer.2020.108295 (2020).","journal-title":"Exp. Eye Res."},{"key":"40211_CR5","doi-asserted-by":"publisher","first-page":"949202","DOI":"10.3389\/fmed.2022.949202","volume":"9","author":"M Soifer","year":"2022","unstructured":"Soifer, M., Azar, N. S., Mousa, H. M. & Perez, V. L. Ocular surface inflammatory disorders (OSID): A collective of systemic etiologies which cause or amplify dry eye syndrome. Front. Med. (Lausanne). 9, 949202. https:\/\/doi.org\/10.3389\/fmed.2022.949202 (2022).","journal-title":"Front. Med. (Lausanne)"},{"key":"40211_CR6","doi-asserted-by":"publisher","first-page":"9271","DOI":"10.3390\/ijms21239271","volume":"21","author":"K Tsubota","year":"2020","unstructured":"Tsubota, K. et al. Defining dry eye from a clinical perspective. Int. J. Mol. Sci. 21, 9271. https:\/\/doi.org\/10.3390\/ijms21239271 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"40211_CR7","doi-asserted-by":"publisher","first-page":"100762","DOI":"10.1016\/j.preteyeres.2019.05.003","volume":"73","author":"MA Al-Aqaba","year":"2019","unstructured":"Al-Aqaba, M. A., Dhillon, V. K., Mohammed, I., Said, D. G. & Dua, H. S. Corneal nerves in health and disease. Prog Retin Eye Res. 73, 100762. https:\/\/doi.org\/10.1016\/j.preteyeres.2019.05.003 (2019).","journal-title":"Prog Retin Eye Res."},{"key":"40211_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.809164","author":"Y Gu","year":"2022","unstructured":"Gu, Y. et al. Corneal in vivo confocal microscopy for assessment of Non-Neurological autoimmune diseases: A Meta-Analysis. Front. Med. https:\/\/doi.org\/10.3389\/fmed.2022.809164 (2022).","journal-title":"Front. Med."},{"key":"40211_CR9","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3390\/biomedicines9101424","volume":"9","author":"A Guerrero-Moreno","year":"2021","unstructured":"Guerrero-Moreno, A. et al. Corneal nerve abnormalities in painful dry eye disease patients. Biomedicines 9, 1424. https:\/\/doi.org\/10.3390\/biomedicines9101424 (2021).","journal-title":"Biomedicines"},{"key":"40211_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12886-021-01967-7","volume":"21","author":"F Li","year":"2021","unstructured":"Li, F. et al. Corneal nerve structure in patients with primary Sj\u00f6gren\u2019s syndrome in China. BMC Ophthalmol. 21, 211. https:\/\/doi.org\/10.1186\/s12886-021-01967-7 (2021).","journal-title":"BMC Ophthalmol."},{"key":"40211_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/2211-5056.369606","volume":"13","author":"A Nguyen","year":"2023","unstructured":"Nguyen, A., Kolluru, A. & Beglarian, T. Dry eye disease: A review of anti-inflammatory therapies. Taiwan. J. Ophthalmol. 13, 3\u201312. https:\/\/doi.org\/10.4103\/2211-5056.369606 (2023).","journal-title":"Taiwan. J. Ophthalmol."},{"key":"40211_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/pharmaceutics15010147","volume":"15","author":"KY Wu","year":"2022","unstructured":"Wu, K. Y., Chen, W. T., Chu-B\u00e9dard, Y. K., Patel, G. & Tran, S. D. Management of sjogren\u2019s dry eye Disease-Advances in ocular drug delivery offering a new hope. Pharmaceutics 15, 147. https:\/\/doi.org\/10.3390\/pharmaceutics15010147 (2022).","journal-title":"Pharmaceutics"},{"key":"40211_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3390\/jcm11020463","volume":"11","author":"H Ahn","year":"2022","unstructured":"Ahn, H. et al. Comparison of treatment modalities for dry eye in primary Sj\u00f6gren\u2019s syndrome. J. Clin. Med. 11, 463. https:\/\/doi.org\/10.3390\/jcm11020463 (2022).","journal-title":"J. Clin. Med."},{"key":"40211_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/bs.pmbts.2015.04.001","volume":"134","author":"AO Eghrari","year":"2015","unstructured":"Eghrari, A. O., Riazuddin, S. A. & Gottsch, J. D. Overview of the cornea: Structure, Function, and development. Prog Mol. Biol. Transl Sci. 134, 7\u201323. https:\/\/doi.org\/10.1016\/bs.pmbts.2015.04.001 (2015).","journal-title":"Prog Mol. Biol. Transl Sci."},{"key":"40211_CR15","doi-asserted-by":"publisher","first-page":"12615","DOI":"10.3390\/ijms241612615","volume":"24","author":"K Feinberg","year":"2023","unstructured":"Feinberg, K. et al. The role of sensory innervation in homeostatic and Injury-Induced corneal epithelial renewal. Int. J. Mol. Sci. 24, 12615. https:\/\/doi.org\/10.3390\/ijms241612615 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"40211_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.survophthal.2013.09.002","volume":"59","author":"BS Shaheen","year":"2014","unstructured":"Shaheen, B. S., Bakir, M. & Jain, S. Corneal nerves in health and disease. Surv. Ophthalmol. 59, 263\u2013285. https:\/\/doi.org\/10.1016\/j.survophthal.2013.09.002 (2014).","journal-title":"Surv. Ophthalmol."},{"key":"40211_CR17","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.3390\/biomedicines10081985","volume":"10","author":"S Puri","year":"2022","unstructured":"Puri, S., Kenyon, B. & Hamrah, M. Immunomodulatory role of neuropeptides in the cornea. Biomedicines 10, 1985. https:\/\/doi.org\/10.3390\/biomedicines10081985 (2022).","journal-title":"Biomedicines"},{"key":"40211_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s42003-024-05934-y","volume":"7","author":"AA Zidan","year":"2024","unstructured":"Zidan, A. A. et al. Topical application of calcitonin gene-related peptide as a regenerative, antifibrotic, and Immunomodulatory therapy for corneal injury. Commun. Biol. 7, 264. https:\/\/doi.org\/10.1038\/s42003-024-05934-y (2024).","journal-title":"Commun. Biol."},{"key":"40211_CR19","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1167\/iovs.16-21372","volume":"58","author":"G Di","year":"2017","unstructured":"Di, G. et al. Corneal Epithelium-Derived neurotrophic factors promote nerve regeneration. Invest. Ophthalmol. Vis. Sci. 58, 4695\u20134702. https:\/\/doi.org\/10.1167\/iovs.16-21372 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"40211_CR20","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.4103\/1673-5374.213534","volume":"12","author":"M Sacchetti","year":"2017","unstructured":"Sacchetti, M. & Lambiase, A. Neurotrophic factors and corneal nerve regeneration. Neural Regen Res. 12, 1220\u20131224. https:\/\/doi.org\/10.4103\/1673-5374.213534 (2017).","journal-title":"Neural Regen Res."},{"key":"40211_CR21","first-page":"163","volume":"8","author":"U Vaidyanathan","year":"2019","unstructured":"Vaidyanathan, U. et al. Persistent corneal epithelial defects: A review Article. Med. Hypothesis Discov Innov. Ophthalmol. 8, 163\u2013176 (2019). https:\/\/pubmed.ncbi.nlm.nih.gov\/31598519","journal-title":"Med. Hypothesis Discov Innov. Ophthalmol."},{"key":"40211_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0002-9440(10)62232-8","volume":"166","author":"SC Pflugfelder","year":"2005","unstructured":"Pflugfelder, S. C. et al. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am. J. Pathol. 166, 61\u201371. https:\/\/doi.org\/10.1016\/S0002-9440(10)62232-8 (2005).","journal-title":"Am. J. Pathol."},{"key":"40211_CR23","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1167\/iovs.08-2476","volume":"50","author":"S Chotikavanich","year":"2009","unstructured":"Chotikavanich, S. et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest. Ophthalmol. Vis. Sci. 50, 3203\u20133209. https:\/\/doi.org\/10.1167\/iovs.08-2476 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"40211_CR24","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1167\/iovs.05-1382","volume":"47","author":"RM Corrales","year":"2006","unstructured":"Corrales, R. M. et al. Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium. Invest. Ophthalmol. Vis. Sci. 47, 3293\u20133302. https:\/\/doi.org\/10.1167\/iovs.05-1382 (2006).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"40211_CR25","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1097\/00004647-200012000-00007","volume":"20","author":"M Asahi","year":"2000","unstructured":"Asahi, M. et al. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme Inhibition with BB-94. J. Cereb. Blood Flow. Metab. 20, 1681\u20131689. https:\/\/doi.org\/10.1097\/00004647-200012000-00007 (2000).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"40211_CR26","doi-asserted-by":"publisher","first-page":"7724","DOI":"10.1523\/JNEUROSCI.21-19-07724.2001","volume":"21","author":"M Asahi","year":"2001","unstructured":"Asahi, M. et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21, 7724\u20137732. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-19-07724.2001 (2001).","journal-title":"J. Neurosci."},{"key":"40211_CR27","doi-asserted-by":"publisher","first-page":"7037","DOI":"10.1523\/JNEUROSCI.20-18-07037.2000","volume":"20","author":"X Wang","year":"2000","unstructured":"Wang, X. et al. Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J. Neurosci. 20, 7037\u20137042. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-18-07037.2000 (2000).","journal-title":"J. Neurosci."},{"key":"40211_CR28","doi-asserted-by":"publisher","first-page":"47461","DOI":"10.1074\/jbc.M204824200","volume":"277","author":"SK Chintala","year":"2002","unstructured":"Chintala, S. K., Zhang, X., Austin, J. S. & Fini, M. E. Deficiency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation. J. Biol. Chem. 277, 47461\u201347468. https:\/\/doi.org\/10.1074\/jbc.M204824200 (2002).","journal-title":"J. Biol. Chem."},{"key":"40211_CR29","doi-asserted-by":"publisher","first-page":"e48332","DOI":"10.1371\/journal.pone.0048332","volume":"7","author":"AR Santos","year":"2012","unstructured":"Santos, A. R. et al. \u03b21 integrin-focal adhesion kinase (FAK) signaling modulates retinal ganglion cell (RGC) survival. PLoS One. 7, e48332. https:\/\/doi.org\/10.1371\/journal.pone.0048332 (2012).","journal-title":"PLoS One"},{"key":"40211_CR30","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/ijms22010116","volume":"22","author":"ME Fini","year":"2020","unstructured":"Fini, M. E., Jeong, S. & Wilson, M. R. Therapeutic potential of the molecular chaperone and matrix metalloproteinase inhibitor clusterin for dry eye. Int. J. Mol. Sci. 22, 116. https:\/\/doi.org\/10.3390\/ijms22010116 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"40211_CR31","doi-asserted-by":"publisher","unstructured":"Gordon, G. M., Fini, M. E. & D\u2019Amore, P. A. ). Corneal wound healing: optical clarity, cytokines and growth factors, matrix metalloproteinases. encyclopedia of the eye (Second Edition), 147\u2013155 Elsevier, Oxford, (2025). https:\/\/doi.org\/10.1016\/B978-0-443-13820-1.00137-7 (2025).","DOI":"10.1016\/B978-0-443-13820-1.00137-7"},{"key":"40211_CR32","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.ajpath.2012.01.025","volume":"180","author":"S Jeong","year":"2012","unstructured":"Jeong, S. et al. Interaction of clusterin and matrix metalloproteinase-9 and its implication for epithelial homeostasis and inflammation. Am. J. Pathol. 180, 2028\u20132039. https:\/\/doi.org\/10.1016\/j.ajpath.2012.01.025 (2012).","journal-title":"Am. J. Pathol."},{"key":"40211_CR33","doi-asserted-by":"publisher","first-page":"36350","DOI":"10.1074\/jbc.M301509200","volume":"278","author":"A Matsuda","year":"2003","unstructured":"Matsuda, A. et al. Clusterin, an abundant serum factor, is a possible negative regulator of MT6-MMP\/MMP-25 produced by neutrophils. J. Biol. Chem. 278, 36350\u201336357. https:\/\/doi.org\/10.1074\/jbc.M301509200 (2003).","journal-title":"J. Biol. Chem."},{"key":"40211_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.exer.2016.04.019","volume":"147","author":"ME Fini","year":"2016","unstructured":"Fini, M. E., Bauskar, A., Jeong, S. & Wilson, M. R. Clusterin in the eye: an old dog with new tricks at the ocular surface. Exp. Eye Res. 147, 57\u201371. https:\/\/doi.org\/10.1016\/j.exer.2016.04.019 (2016).","journal-title":"Exp. Eye Res."},{"key":"40211_CR35","doi-asserted-by":"publisher","first-page":"101032","DOI":"10.1016\/j.preteyeres.2021.101032","volume":"89","author":"MR Wilson","year":"2022","unstructured":"Wilson, M. R., Satapathy, S., Jeong, S. & Fini, M. E. Clusterin, other extracellular chaperones, and eye disease. Prog Retin Eye Res. 89, 101032. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.101032 (2022).","journal-title":"Prog Retin Eye Res."},{"key":"40211_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-biochem-072711-163904","volume":"82","author":"AR Wyatt","year":"2013","unstructured":"Wyatt, A. R., Yerbury, J. J., Ecroyd, H. & Wilson, M. R. Extracellular chaperones and proteostasis. Annu. Rev. Biochem. 82, 295\u2013322. https:\/\/doi.org\/10.1146\/annurev-biochem-072711-163904 (2013).","journal-title":"Annu. Rev. Biochem."},{"key":"40211_CR37","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1002\/jcp.30769","volume":"237","author":"A Soundararajan","year":"2022","unstructured":"Soundararajan, A., Wang, T., Ghag, S. A., Kang, M. H. & Pattabiraman, P. P. Novel insight into the role of clusterin on intraocular pressure regulation by modifying actin polymerization and extracellular matrix remodeling in the trabecular meshwork. J. Cell. Physiol. 237, 3012\u20133029. https:\/\/doi.org\/10.1002\/jcp.30769 (2022).","journal-title":"J. Cell. Physiol."},{"key":"40211_CR38","first-page":"1702","volume":"43","author":"T Nakamura","year":"2002","unstructured":"Nakamura, T., Nishida, K., Dota, A. & Kinoshita, S. Changes in conjunctival clusterin expression in severe ocular surface disease. Invest. Ophthalmol. Vis. Sci. 43, 1702\u20131707 (2002). https:\/\/pubmed.ncbi.nlm.nih.gov\/12036968","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"40211_CR39","first-page":"1800","volume":"37","author":"K Nishida","year":"1996","unstructured":"Nishida, K. et al. A gene expression profile of human corneal epithelium and the isolation of human keratin 12 cDNA. Invest. Ophthalmol. Vis. Sci. 37, 1800\u20131809 (1996). https:\/\/pubmed.ncbi.nlm.nih.gov\/8759347","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"40211_CR40","first-page":"2285","volume":"37","author":"K Nishida","year":"1996","unstructured":"Nishida, K., Kawasaki, S., Adachi, W. & Kinoshita, S. Apolipoprotein J expression in human ocular surface epithelium. Invest. Ophthalmol. Vis. Sci. 37, 2285\u20132292 (1996). https:\/\/pubmed.ncbi.nlm.nih.gov\/8843912","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"40211_CR41","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/978-1-4615-5359-5_89","volume":"438","author":"K Nishida","year":"1998","unstructured":"Nishida, K., Kawasaki, S. & Kinoshita, S. Clusterin May be essential for maintaining ocular surface epithelium as a non-keratinizing epithelium. Adv. Exp. Med. Biol. 438, 629\u2013635. https:\/\/doi.org\/10.1007\/978-1-4615-5359-5_89 (1998).","journal-title":"Adv. Exp. Med. Biol."},{"key":"40211_CR42","doi-asserted-by":"publisher","first-page":"6875","DOI":"10.1074\/jbc.274.11.6875","volume":"274","author":"DT Humphreys","year":"1999","unstructured":"Humphreys, D. T., Carver, J. A., Easterbrook-Smith, S. B. & Wilson, M. R. Clusterin has chaperone-like activity similar to that of small heat shock proteins. J. Biol. Chem. 274, 6875\u20136881. https:\/\/doi.org\/10.1074\/jbc.274.11.6875 (1999).","journal-title":"J. Biol. Chem."},{"key":"40211_CR43","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/0006-291x(91)90635-k","volume":"177","author":"MR Wilson","year":"1991","unstructured":"Wilson, M. R., Roeth, P. J. & Easterbrook-Smith, S. B. Clusterin enhances the formation of insoluble immune complexes. Biochem. Biophys. Res. Commun. 177, 985\u2013990. https:\/\/doi.org\/10.1016\/0006-291x(91)90635-k (1991).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"40211_CR44","doi-asserted-by":"publisher","first-page":"e0138958","DOI":"10.1371\/journal.pone.0138958","volume":"10","author":"A Bauskar","year":"2015","unstructured":"Bauskar, A. et al. Clusterin seals the ocular surface barrier in mouse dry eye. PLoS One. 10, e0138958. https:\/\/doi.org\/10.1371\/journal.pone.0138958 (2015).","journal-title":"PLoS One"},{"key":"40211_CR45","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/ijms24020981","volume":"24","author":"SK Chintala","year":"2023","unstructured":"Chintala, S. K. et al. Recombinant human clusterin seals damage to the ocular surface barrier in a mouse model of ophthalmic Preservative-Induced epitheliopathy. Int. J. Mol. Sci. 24, 981. https:\/\/doi.org\/10.3390\/ijms24020981 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"40211_CR46","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.jtos.2018.08.001","volume":"16","author":"V Yu","year":"2018","unstructured":"Yu, V. et al. Clusterin from human clinical tear samples: positive correlation between tear concentration and schirmer strip test results. Ocul Surf. 16, 478\u2013486. https:\/\/doi.org\/10.1016\/j.jtos.2018.08.001 (2018).","journal-title":"Ocul Surf."},{"key":"40211_CR47","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.2353\/ajpath.2009.081058","volume":"175","author":"B Turpie","year":"2009","unstructured":"Turpie, B. et al. Sj\u00f6gren\u2019s syndrome-like ocular surface disease in thrombospondin-1 deficient mice. Am. J. Pathol. 175, 1136\u20131147. https:\/\/doi.org\/10.2353\/ajpath.2009.081058 (2009).","journal-title":"Am. J. Pathol."},{"key":"40211_CR48","doi-asserted-by":"publisher","first-page":"e75937","DOI":"10.1371\/journal.pone.0075937","volume":"8","author":"L Contreras-Ruiz","year":"2013","unstructured":"Contreras-Ruiz, L., Regenfuss, B., Mir, F. A., Kearns, J. & Masli, S. Conjunctival inflammation in thrombospondin-1 deficient mouse model of Sj\u00f6gren\u2019s syndrome. PLoS One. 8, e75937. https:\/\/doi.org\/10.1371\/journal.pone.0075937 (2013).","journal-title":"PLoS One"},{"key":"40211_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exer.2015.10.008","volume":"143","author":"L Contreras-Ruiz","year":"2016","unstructured":"Contreras-Ruiz, L., Mir, F. A., Turpie, B., Krauss, A. H. & Masli, S. Sj\u00f6gren\u2019s syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin \u03b14 antagonist GW559090. Exp. Eye Res. 143, 1\u20138. https:\/\/doi.org\/10.1016\/j.exer.2015.10.008 (2016).","journal-title":"Exp. Eye Res."},{"key":"40211_CR50","doi-asserted-by":"publisher","first-page":"9112","DOI":"10.3390\/ijms21239112","volume":"21","author":"S Masli","year":"2020","unstructured":"Masli, S. & Dartt, D. A. Mouse models of Sj\u00f6gren\u2019s syndrome with ocular surface disease. Int. J. Mol. Sci. 21, 9112. https:\/\/doi.org\/10.3390\/ijms21239112 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"40211_CR51","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jtos.2022.07.003","volume":"25","author":"J Luzu","year":"2022","unstructured":"Luzu, J. et al. In vivo confocal microscopic study of corneal innervation in Sj\u00f6gren\u2019s syndrome with or without small fiber neuropathy. Ocul Surf. 25, 155\u2013162. https:\/\/doi.org\/10.1016\/j.jtos.2022.07.003 (2022).","journal-title":"Ocul Surf."},{"key":"40211_CR52","doi-asserted-by":"publisher","first-page":"CD015070","DOI":"10.1002\/14651858.CD015070.pub2","volume":"10","author":"SH Liu","year":"2022","unstructured":"Liu, S. H. et al. Topical corticosteroids for dry eye. Cochrane Database Syst. Rev. 10, CD015070. https:\/\/doi.org\/10.1002\/14651858.CD015070.pub2 (2022).","journal-title":"Cochrane Database Syst. Rev."},{"key":"40211_CR53","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/cei.12919","volume":"188","author":"L Contreras Ruiz","year":"2017","unstructured":"Contreras Ruiz, L., Mir, F. A., Turpie, B. & Masli, S. Thrombospondin-derived peptide attenuates Sj\u00f6gren\u2019s syndrome-associated ocular surface inflammation in mice. Clin. Exp. Immunol. 188, 86\u201395. https:\/\/doi.org\/10.1111\/cei.12919 (2017).","journal-title":"Clin. Exp. Immunol."},{"key":"40211_CR54","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.3390\/ijms19103191","volume":"19","author":"Y Tatematsu","year":"2018","unstructured":"Tatematsu, Y. et al. Thrombospondin-1 is necessary for the development and repair of corneal nerves. Int. J. Mol. Sci. 19, 3191. https:\/\/doi.org\/10.3390\/ijms19103191 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"40211_CR55","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1167\/iovs.15-18019","volume":"57","author":"J He","year":"2016","unstructured":"He, J. & Bazan, H. E. Neuroanatomy and neurochemistry of mouse cornea. Invest. Ophthalmol. Vis. Sci. 57, 664\u2013674. https:\/\/doi.org\/10.1167\/iovs.15-18019 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"40211_CR56","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.celrep.2018.07.029","volume":"24","author":"A Latremoliere","year":"2018","unstructured":"Latremoliere, A. et al. Neuronal-Specific TUBB3 is not required for normal neuronal function but is essential for timely axon regeneration. Cell. Rep. 24, 1865\u20131879. https:\/\/doi.org\/10.1016\/j.celrep.2018.07.029 (2018). .e9.","journal-title":"Cell. Rep."},{"key":"40211_CR57","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.exer.2010.07.007","volume":"91","author":"J He","year":"2010","unstructured":"He, J., Bazan, N. G. & Bazan, H. E. Mapping the entire human corneal nerve architecture. Exp. Eye Res. 91, 513\u2013523. https:\/\/doi.org\/10.1016\/j.exer.2010.07.007 (2010).","journal-title":"Exp. Eye Res."},{"key":"40211_CR58","doi-asserted-by":"publisher","first-page":"1210179","DOI":"10.3389\/fnins.2023.1210179","volume":"17","author":"A Balbuena-Pareja","year":"2023","unstructured":"Balbuena-Pareja, A., Bogen, C. S., Cox, S. M. & Hamrah, P. Effect of Recombinant human nerve growth factor treatment on corneal nerve regeneration in patients with neurotrophic keratopathy. Front. Neurosci. 17, 1210179. https:\/\/doi.org\/10.3389\/fnins.2023.1210179 (2023).","journal-title":"Front. Neurosci."},{"key":"40211_CR59","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1001\/archophthalmol.2011.287","volume":"130","author":"MS Cortina","year":"2012","unstructured":"Cortina, M. S., He, J., Li, N., Bazan, N. G. & Bazan, H. E. Recovery of corneal sensitivity, calcitonin gene-related peptide-positive nerves, and increased wound healing induced by pigment epithelial-derived factor plus docosahexaenoic acid after experimental surgery. Arch. Ophthalmol. 130, 76\u201383. https:\/\/doi.org\/10.1001\/archophthalmol.2011.287 (2012).","journal-title":"Arch. Ophthalmol."},{"key":"40211_CR60","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/s0161-6420(97)30330-3","volume":"104","author":"SC Pflugfelder","year":"1997","unstructured":"Pflugfelder, S. C. et al. Correlation of goblet cell density and mucosal epithelial membrane mucin expression with Rose Bengal staining in patients with ocular irritation. Ophthalmology 104, 223\u2013235. https:\/\/doi.org\/10.1016\/s0161-6420(97)30330-3 (1997).","journal-title":"Ophthalmology"},{"key":"40211_CR61","doi-asserted-by":"publisher","first-page":"7545","DOI":"10.1167\/iovs.15-17627","volume":"56","author":"SC Pflugfelder","year":"2015","unstructured":"Pflugfelder, S. C. et al. Aqueous tear deficiency increases conjunctival Interferon-\u03b3 (IFN-\u03b3) expression and goblet cell loss. Invest. Ophthalmol. Vis. Sci. 56, 7545\u20137550. https:\/\/doi.org\/10.1167\/iovs.15-17627 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"40211_CR62","doi-asserted-by":"publisher","unstructured":"Contreras-Ruiz, L., Ghosh-Mitra, A., Shatos, M. A., Dartt, D. A. & Masli, S. Modulation of conjunctival goblet cell function by inflammatory cytokines. Mediators Inflamm 636812. (2013). https:\/\/doi.org\/10.1155\/2013\/636812 (2013).","DOI":"10.1155\/2013\/636812"},{"key":"40211_CR63","doi-asserted-by":"publisher","unstructured":"Trotta, M. C. et al. Oral Administration of Vitamin D3 Prevents Corneal Damage in a Knock-Out Mouse Model of Sj\u00f6gren\u2019s Syndrome. Biomedicines 11, 616. (2023). https:\/\/doi.org\/10.3390\/biomedicines11020616","DOI":"10.3390\/biomedicines11020616"},{"key":"40211_CR64","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/385729a0","volume":"385","author":"RA Black","year":"1997","unstructured":"Black, R. A. et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385, 729\u2013733. https:\/\/doi.org\/10.1038\/385729a0 (1997).","journal-title":"Nature"},{"key":"40211_CR65","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/385733a0","volume":"385","author":"ML Moss","year":"1997","unstructured":"Moss, M. L. et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385, 733\u2013736. https:\/\/doi.org\/10.1038\/385733a0 (1997).","journal-title":"Nature"},{"key":"40211_CR66","doi-asserted-by":"publisher","unstructured":"Pflugfelder, S. C. & de Paiva, C. S. The pathophysiology of dry eye disease: what we know and future directions for research. Ophthalmology 124 https:\/\/doi.org\/10.1016\/j.ophtha.2017.07.010 (2017). S4-S13.","DOI":"10.1016\/j.ophtha.2017.07.010"},{"key":"40211_CR67","unstructured":"Chourpiliadis, C., Aeddula, N. R. & Physiology Glucocorticoids. In StatPearls (StatPearls Publishing, Treasure Island (FL), (2025)."},{"key":"40211_CR68","unstructured":"Hodgens, A. & Sharman, T. Corticosteroids. In StatPearls (StatPearls Publishing, Treasure Island (FL), (2025)."},{"key":"40211_CR69","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3389\/fimmu.2019.01545","volume":"10","author":"S Timmermans","year":"2019","unstructured":"Timmermans, S., Souffriau, J. & Libert, C. A general introduction to glucocorticoid biology. Front. Immunol. 10, 1545. https:\/\/doi.org\/10.3389\/fimmu.2019.01545 (2019).","journal-title":"Front. Immunol."},{"key":"40211_CR70","doi-asserted-by":"publisher","first-page":"CD010051","DOI":"10.1002\/14651858.CD010051.pub2","volume":"9","author":"CS de Paiva","year":"2019","unstructured":"de Paiva, C. S., Pflugfelder, S. C., Ng, S. M. & Akpek, E. K. Topical cyclosporine A therapy for dry eye syndrome. Cochrane Database Syst. Rev. 9, CD010051. https:\/\/doi.org\/10.1002\/14651858.CD010051.pub2 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"40211_CR71","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1080\/03007995.2016.1210107","volume":"32","author":"EJ Holland","year":"2016","unstructured":"Holland, E. J. et al. Lifitegrast clinical efficacy for treatment of signs and symptoms of dry eye disease across three randomized controlled trials. Curr. Med. Res. Opin. 32, 1759\u20131765. https:\/\/doi.org\/10.1080\/03007995.2016.1210107 (2016).","journal-title":"Curr. Med. Res. Opin."},{"key":"40211_CR72","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ophtha.2016.09.025","volume":"124","author":"EJ Holland","year":"2017","unstructured":"Holland, E. J. et al. Lifitegrast for the treatment of dry eye disease: results of a phase III, Randomized, Double-Masked, Placebo-Controlled trial (OPUS-3). Ophthalmology 124, 53\u201360. https:\/\/doi.org\/10.1016\/j.ophtha.2016.09.025 (2017).","journal-title":"Ophthalmology"},{"key":"40211_CR73","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.ophtha.2014.11.006","volume":"122","author":"A Kheirkhah","year":"2015","unstructured":"Kheirkhah, A. et al. Effects of corneal nerve density on the response to treatment in dry eye disease. Ophthalmology 122, 662\u2013668. https:\/\/doi.org\/10.1016\/j.ophtha.2014.11.006 (2015).","journal-title":"Ophthalmology"},{"key":"40211_CR74","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/ICO.0000000000003363","volume":"43","author":"JY Chin","year":"2024","unstructured":"Chin, J. Y. et al. Impact of age on the characteristics of corneal nerves and corneal epithelial cells in healthy adults. Cornea 43, 409\u2013418. https:\/\/doi.org\/10.1097\/ICO.0000000000003363 (2024).","journal-title":"Cornea"},{"key":"40211_CR75","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.preteyeres.2018.11.005","volume":"71","author":"TB McKay","year":"2019","unstructured":"McKay, T. B. et al. Corneal pain and experimental model development. Prog Retin Eye Res. 71, 88\u2013113. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.11.005 (2019).","journal-title":"Prog Retin Eye Res."},{"key":"40211_CR76","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-021-00426-7","volume":"16","author":"F Chen","year":"2021","unstructured":"Chen, F. et al. Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates alzheimer\u2019s disease neuropathology. Mol. Neurodegener. 16, 5. https:\/\/doi.org\/10.1186\/s13024-021-00426-7 (2021).","journal-title":"Mol. Neurodegener"},{"key":"40211_CR77","doi-asserted-by":"publisher","unstructured":"Fareed, M. M. et al. The Role of Clusterin Transporter in the Pathogenesis of Alzheimer\u2019s Disease at the Blood-Brain Barrier Interface: A Systematic Review. Biomolecules 12, 1452. (2022). https:\/\/doi.org\/10.3390\/biom12101452","DOI":"10.3390\/biom12101452"},{"key":"40211_CR78","doi-asserted-by":"publisher","first-page":"e48255","DOI":"10.7554\/eLife.48255","volume":"8","author":"SK Herring","year":"2019","unstructured":"Herring, S. K., Moon, H. J., Rawal, P., Chhibber, A. & Zhao, L. Brain clusterin protein isoforms and mitochondrial localization. Elife 8, e48255. https:\/\/doi.org\/10.7554\/eLife.48255 (2019).","journal-title":"Elife"},{"key":"40211_CR79","doi-asserted-by":"publisher","first-page":"111307","DOI":"10.1016\/j.celrep.2022.111307","volume":"40","author":"Y Efraim","year":"2022","unstructured":"Efraim, Y. et al. A synthetic tear protein resolves dry eye through promoting corneal nerve regeneration. Cell. Rep. 40, 111307. https:\/\/doi.org\/10.1016\/j.celrep.2022.111307 (2022).","journal-title":"Cell. Rep."},{"key":"40211_CR80","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jtos.2016.09.004","volume":"15","author":"A Cruzat","year":"2017","unstructured":"Cruzat, A., Qazi, Y. & Hamrah, P. Vivo confocal microscopy of corneal nerves in health and disease. Ocul Surf. 15, 15\u201347. https:\/\/doi.org\/10.1016\/j.jtos.2016.09.004 (2017).","journal-title":"Ocul Surf."},{"key":"40211_CR81","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13023-022-02237-5","volume":"17","author":"E Pedrotti","year":"2022","unstructured":"Pedrotti, E. et al. Eight months follow-up of corneal nerves and sensitivity after treatment with cenegermin for neurotrophic keratopathy. Orphanet J. Rare Dis. 17, 63. https:\/\/doi.org\/10.1186\/s13023-022-02237-5 (2022).","journal-title":"Orphanet J. Rare Dis."},{"key":"40211_CR82","first-page":"1533","volume":"29","author":"B Ebato","year":"1988","unstructured":"Ebato, B., Friend, J. & Thoft, R. A. Comparison of limbal and peripheral human corneal epithelium in tissue culture. Invest. Ophthalmol. Vis. Sci. 29, 1533\u20131537 (1988). https:\/\/pubmed.ncbi.nlm.nih.gov\/3170124","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"40211_CR83","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12886-016-0290-5","volume":"16","author":"T Zheng","year":"2016","unstructured":"Zheng, T., Le, Q., Hong, J. & Xu, J. Comparison of human corneal cell density by age and corneal location: an in vivo confocal microscopy study. BMC Ophthalmol. 16, 109. https:\/\/doi.org\/10.1186\/s12886-016-0290-5 (2016).","journal-title":"BMC Ophthalmol."},{"key":"40211_CR84","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1089\/jop.1996.12.417","volume":"12","author":"AA Mikulec","year":"1996","unstructured":"Mikulec, A. A. & Tanelian, D. L. CGRP increases the rate of corneal re-epithelialization in an in vitro whole Mount Preparation. J. Ocul Pharmacol. Ther. 12, 417\u2013423. https:\/\/doi.org\/10.1089\/jop.1996.12.417 (1996).","journal-title":"J. Ocul Pharmacol. Ther."},{"key":"40211_CR85","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/363159a0","volume":"363","author":"J Hosoi","year":"1993","unstructured":"Hosoi, J. et al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 363, 159\u2013163. https:\/\/doi.org\/10.1038\/363159a0 (1993).","journal-title":"Nature"},{"key":"40211_CR86","doi-asserted-by":"publisher","first-page":"e2215","DOI":"10.1038\/cddis.2016.113","volume":"7","author":"P Cunin","year":"2016","unstructured":"Cunin, P. et al. Clusterin facilitates apoptotic cell clearance and prevents apoptotic cell-induced autoimmune responses. Cell. Death Dis. 7, e2215. https:\/\/doi.org\/10.1038\/cddis.2016.113 (2016).","journal-title":"Cell. Death Dis."},{"key":"40211_CR87","doi-asserted-by":"publisher","first-page":"e2407648121","DOI":"10.1073\/pnas.2407648121","volume":"121","author":"A Vereertbrugghen","year":"2024","unstructured":"Vereertbrugghen, A. et al. CD4+ T cells drive corneal nerve damage but not epitheliopathy in an acute aqueous-deficient dry eye model. Proc. Natl. Acad. Sci. U S A. 121, e2407648121. https:\/\/doi.org\/10.1073\/pnas.2407648121 (2024).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"40211_CR88","doi-asserted-by":"publisher","first-page":"1362336","DOI":"10.3389\/fmed.2024.1362336","volume":"11","author":"J Alam","year":"2024","unstructured":"Alam, J. et al. Single cell analysis of short-term dry eye induced changes in cornea immune cell populations. Front. Med. (Lausanne). 11, 1362336. https:\/\/doi.org\/10.3389\/fmed.2024.1362336 (2024).","journal-title":"Front. Med. (Lausanne)"},{"key":"40211_CR89","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1002\/ar.24597","volume":"304","author":"A DeSantis-Rodrigues","year":"2021","unstructured":"DeSantis-Rodrigues, A. et al. SM1997 downregulates mustard-induced enzymes that disrupt corneal epithelial attachment. Anat. Rec (Hoboken). 304, 1974\u20131983. https:\/\/doi.org\/10.1002\/ar.24597 (2021).","journal-title":"Anat. Rec (Hoboken)"},{"key":"40211_CR90","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.biocel.2010.03.011","volume":"42","author":"KV Ramana","year":"2010","unstructured":"Ramana, K. V. Tumor necrosis factor-alpha converting enzyme: implications for ocular inflammatory diseases. Int. J. Biochem. Cell. Biol. 42, 1076\u20131079. https:\/\/doi.org\/10.1016\/j.biocel.2010.03.011 (2010).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"40211_CR91","first-page":"4922","volume":"57","author":"MK Gordon","year":"2016","unstructured":"Gordon, M. K. et al. Inhibiting ADAM17 after ocular mustard exposure reduces EMMPRIN expression as well as MMP-9 activation. Invest. Ophthalmol. Visual Sci. Invest. Ophthalmol. Vis. Sci. 57, 4922 (2016).","journal-title":"Invest. Ophthalmol. Visual Sci. Invest. Ophthalmol. Vis. Sci."},{"key":"40211_CR92","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/nyas.13226","volume":"1378","author":"MK Gordon","year":"2016","unstructured":"Gordon, M. K. et al. The molecules in the corneal basement membrane zone affected by mustard exposure suggest potential therapies. Ann. N Y Acad. Sci. 1378, 158\u2013165. https:\/\/doi.org\/10.1111\/nyas.13226 (2016).","journal-title":"Ann. N Y Acad. Sci."},{"key":"40211_CR93","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1210\/en.2013-1870","volume":"155","author":"MJ Kwon","year":"2014","unstructured":"Kwon, M. J. et al. Deficiency of clusterin exacerbates high-fat diet-induced insulin resistance in male mice. Endocrinology 155, 2089\u20132101. https:\/\/doi.org\/10.1210\/en.2013-1870 (2014).","journal-title":"Endocrinology"},{"key":"40211_CR94","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1172\/JCI9037","volume":"106","author":"L McLaughlin","year":"2000","unstructured":"McLaughlin, L. et al. Apolipoprotein J\/clusterin limits the severity of murine autoimmune myocarditis. J. Clin. Invest. 106, 1105\u20131113. https:\/\/doi.org\/10.1172\/JCI9037 (2000).","journal-title":"J. Clin. Invest."},{"key":"40211_CR95","first-page":"597","volume":"26","author":"MM Newkirk","year":"1999","unstructured":"Newkirk, M. M., Apostolakos, P., Neville, C. & Fortin, P. R. Systemic lupus erythematosus, a disease associated with low levels of clusterin\/apoJ, an antiinflammatory protein. J. Rheumatol. 26, 597\u2013603 (1999). https:\/\/pubmed.ncbi.nlm.nih.gov\/10090169","journal-title":"J. Rheumatol."},{"key":"40211_CR96","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1164\/rccm.202207-1253OC","volume":"208","author":"JF Augusto","year":"2023","unstructured":"Augusto, J. F. et al. Clusterin neutralizes the inflammatory and cytotoxic properties of extracellular histones in sepsis. Am. J. Respir Crit. Care Med. 208, 176\u2013187. https:\/\/doi.org\/10.1164\/rccm.202207-1253OC (2023).","journal-title":"Am. J. Respir Crit. Care Med."},{"key":"40211_CR97","doi-asserted-by":"publisher","first-page":"610342","DOI":"10.3389\/fncel.2020.610342","volume":"14","author":"A Guerrero-Moreno","year":"2020","unstructured":"Guerrero-Moreno, A., Baudouin, C., Melik Parsadaniantz, S. & Goazigo, R. L. Morphological and functional changes of corneal nerves and their contribution to peripheral and central sensory abnormalities. Front. Cell. Neurosci. 14, 610342. https:\/\/doi.org\/10.3389\/fncel.2020.610342 (2020).","journal-title":"Front. Cell. Neurosci."},{"key":"40211_CR98","doi-asserted-by":"publisher","first-page":"e86989","DOI":"10.1371\/journal.pone.0086989","volume":"9","author":"RA Dabbs","year":"2014","unstructured":"Dabbs, R. A. & Wilson, M. R. Expression and purification of chaperone-active Recombinant clusterin. PLoS One. 9, e86989. https:\/\/doi.org\/10.1371\/journal.pone.0086989 (2014).","journal-title":"PLoS One"},{"key":"40211_CR99","doi-asserted-by":"publisher","first-page":"14243","DOI":"10.1038\/s41598-020-70990-3","volume":"10","author":"S Satapathy","year":"2020","unstructured":"Satapathy, S., Dabbs, R. A. & Wilson, M. R. Rapid high-yield expression and purification of fully post-translationally modified Recombinant clusterin and mutants. Sci. Rep. 10, 14243. https:\/\/doi.org\/10.1038\/s41598-020-70990-3 (2020).","journal-title":"Sci. Rep."},{"key":"40211_CR100","first-page":"221","volume":"21","author":"MA Lemp","year":"1995","unstructured":"Lemp, M. A. Report of the National eye Institute\/Industry workshop on clinical trials in dry eyes. CLAO J. 21, 221\u2013232 (1995). https:\/\/pubmed.ncbi.nlm.nih.gov\/8565190","journal-title":"CLAO J."},{"key":"40211_CR101","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods. 9, 676\u2013682. https:\/\/doi.org\/10.1038\/nmeth.2019 (2012).","journal-title":"Nat. Methods"},{"key":"40211_CR102","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1109\/34.659930","volume":"20","author":"C Steger","year":"1998","unstructured":"Steger, C. An unbiased detector of curvilinear structures. IEEE Trans. Pattern Anal. Mach. Intell. 20, 113\u2013125 (1998). https:\/\/ieeexplore.ieee.org\/abstract\/document\/659930","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"40211_CR103","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/cyto.a.20022","volume":"58","author":"E Meijering","year":"2004","unstructured":"Meijering, E. et al. Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytometry A. 58, 167\u2013176. https:\/\/doi.org\/10.1002\/cyto.a.20022 (2004).","journal-title":"Cytometry A"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40211-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40211-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40211-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:05:34Z","timestamp":1773785134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40211-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,15]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["40211"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-40211-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,15]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.E.F. is a co-founder of Proteris Biotech and an employee of the company, serving as Chief Scientific Officer. S.M. and M.R.W. hold equity in Proteris Biotech and serve on the Medical and Scientific Advisory Board. She is also affiliated with the New England Eye Center, Tufts Medical Center and the Department of Ophthalmology, Tufts University School of Medicine, Boston MA 02115 USA. M.E.F. is named as a co-inventor on U.S. patent number 9241974 entitled \u201cClusterin Pharmaceuticals and Treatment Methods Using the Same\u201d granted to the University of Southern California and optioned for exclusive license to Proteris Biotech. S.M. and M.E.F. are named as co-inventors on a preliminary U.S. patent application co-submitted by Boston University and Proteris Biotech, claiming some of the new findings of this study (63\/734,859). All other authors declare that they do not have any competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9135"}}